Biotech News

Charles River and Autolomous Partner to Transform Laboratory Execution Systems

Charles River (CRL)Charles River2026-10-06 12:00 ESTFDA / regulatory

Partnership reinforces continued investment in digitization, automation, and client-facing transparency WILMINGTON, Mass. & LONDON --(BUSINESS WIRE)--Oct. 6, 2026-- Charles River Laboratories International, Inc. (NYSE: CRL) and Autolomous today announced the launch of Apollo Orchestrate™, a new

Related news

CRLCharles River2026-09-17 12:00 EST

Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines

CRLCharles River2026-09-11 12:00 EST

Charles River Laboratories to Present at Morgan Stanley and Baird Conferences

View all latest news

Charles River

Preclinical Research Services Charles River Laboratories provides products and outsourced services used by pharmaceutical, biotechnology, academic and government researchers across early drug development. Research Models and Services The company supplies research models and related services used in basic research, target validation and...

Recent company news

CRLCharles River2026-10-06 12:00 EST

Charles River and Autolomous Partner to Transform Laboratory Execution Systems

CRLCharles River2026-09-24 12:00 EST

Charles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor Day

CRLCharles River2026-09-17 12:00 EST

Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines

CRLCharles River2026-09-11 12:00 EST

Charles River Laboratories to Present at Morgan Stanley and Baird Conferences

CRLCharles River2026-09-08 12:00 EST

Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite

Stock data

Close: 304.96 USD
Market cap: 8.42B USD
Exchange: NYSE
Sector: Biopharma
Location: United States